Xenogeneic humoral graft-Vs-host disease following hamster-to-Rat bone marrow transplantation. 2000

T Miki, and Y H Lee, and A Tandin, and V Subbotin, and R Kuddus, and A S Rao, and J J Fung, and T E Starzl, and L A Valdivia
Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D011917 Rats, Inbred Lew An inbred strain of rat that is used in BIOMEDICAL RESEARCH. Rats, Inbred Lewis,Rats, Lew,Inbred Lew Rat,Inbred Lew Rats,Inbred Lewis Rats,Lew Rat,Lew Rat, Inbred,Lew Rats,Lew Rats, Inbred,Lewis Rats, Inbred,Rat, Inbred Lew,Rat, Lew
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D013156 Splenectomy Surgical procedure involving either partial or entire removal of the spleen. Splenectomies

Related Publications

T Miki, and Y H Lee, and A Tandin, and V Subbotin, and R Kuddus, and A S Rao, and J J Fung, and T E Starzl, and L A Valdivia
July 1986, Nederlands tijdschrift voor geneeskunde,
T Miki, and Y H Lee, and A Tandin, and V Subbotin, and R Kuddus, and A S Rao, and J J Fung, and T E Starzl, and L A Valdivia
January 1981, Heart & lung : the journal of critical care,
T Miki, and Y H Lee, and A Tandin, and V Subbotin, and R Kuddus, and A S Rao, and J J Fung, and T E Starzl, and L A Valdivia
April 2003, Zhongguo shi yan xue ye xue za zhi,
T Miki, and Y H Lee, and A Tandin, and V Subbotin, and R Kuddus, and A S Rao, and J J Fung, and T E Starzl, and L A Valdivia
January 1984, Journal of the Association of Pediatric Oncology Nurses,
T Miki, and Y H Lee, and A Tandin, and V Subbotin, and R Kuddus, and A S Rao, and J J Fung, and T E Starzl, and L A Valdivia
February 1997, Hematology and cell therapy,
T Miki, and Y H Lee, and A Tandin, and V Subbotin, and R Kuddus, and A S Rao, and J J Fung, and T E Starzl, and L A Valdivia
January 1983, Progress in clinical and biological research,
T Miki, and Y H Lee, and A Tandin, and V Subbotin, and R Kuddus, and A S Rao, and J J Fung, and T E Starzl, and L A Valdivia
March 2007, Pediatric transplantation,
T Miki, and Y H Lee, and A Tandin, and V Subbotin, and R Kuddus, and A S Rao, and J J Fung, and T E Starzl, and L A Valdivia
June 1987, Archives of dermatology,
T Miki, and Y H Lee, and A Tandin, and V Subbotin, and R Kuddus, and A S Rao, and J J Fung, and T E Starzl, and L A Valdivia
June 2002, Archives of dermatology,
T Miki, and Y H Lee, and A Tandin, and V Subbotin, and R Kuddus, and A S Rao, and J J Fung, and T E Starzl, and L A Valdivia
October 1992, Current opinion in immunology,
Copied contents to your clipboard!